These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37947186)

  • 1. Age- and region-dependent cortical excitability in the zQ175 Huntington disease mouse model.
    Wang Y; Ramandi D; Sepers MD; Mackay JP; Raymond LA
    Hum Mol Genet; 2024 Feb; 33(5):387-399. PubMed ID: 37947186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.
    Indersmitten T; Tran CH; Cepeda C; Levine MS
    J Neurophysiol; 2015 Apr; 113(7):2953-66. PubMed ID: 25673747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington's disease.
    Oikonomou KD; Donzis EJ; Bui MTN; Cepeda C; Levine MS
    J Neurophysiol; 2021 Oct; 126(4):1159-1171. PubMed ID: 34469694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered cortical processing of sensory input in Huntington disease mouse models.
    Sepers MD; Mackay JP; Koch E; Xiao D; Mohajerani MH; Chan AW; Smith-Dijak AI; Ramandi D; Murphy TH; Raymond LA
    Neurobiol Dis; 2022 Jul; 169():105740. PubMed ID: 35460870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease.
    Shobe JL; Donzis EJ; Lee K; Chopra S; Masmanidis SC; Cepeda C; Levine MS
    Neurobiol Dis; 2021 Sep; 157():105447. PubMed ID: 34274461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease.
    Holley SM; Galvan L; Kamdjou T; Cepeda C; Levine MS
    Eur J Neurosci; 2019 Jan; 49(1):79-93. PubMed ID: 30472747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease.
    Yu D; Zarate N; White A; Coates D; Tsai W; Nanclares C; Cuccu F; Yue JS; Brown TG; Mansky RH; Jiang K; Kim H; Nichols-Meade T; Larson SN; Gundry K; Zhang Y; Tomas-Zapico C; Lucas JJ; Benneyworth M; Öz G; Cvetanovic M; Araque A; Gomez-Pastor R
    Acta Neuropathol Commun; 2022 Jun; 10(1):83. PubMed ID: 35659303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthened Inputs from Secondary Motor Cortex to Striatum in a Mouse Model of Compulsive Behavior.
    Corbit VL; Manning EE; Gittis AH; Ahmari SE
    J Neurosci; 2019 Apr; 39(15):2965-2975. PubMed ID: 30737313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex.
    Häggkvist J; Tóth M; Tari L; Varnäs K; Svedberg M; Forsberg A; Nag S; Dominguez C; Munoz-Sanjuan I; Bard J; Wityak J; Varrone A; Halldin C; Mrzljak L
    J Nucl Med; 2017 Apr; 58(4):617-622. PubMed ID: 27856625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington's Disease.
    Holley SM; Oikonomou KD; Swift CM; Mohan L; Matthews B; Vega O; Mkrtchyan G; Cepeda C; Levine MS
    eNeuro; 2022; 9(3):. PubMed ID: 35667848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvalbumin fast-spiking interneurons are selectively altered by paediatric traumatic brain injury.
    Nichols J; Bjorklund GR; Newbern J; Anderson T
    J Physiol; 2018 Apr; 596(7):1277-1293. PubMed ID: 29333742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Disinhibition by Adjustment of PV Intrinsic Excitability during Whisker Map Plasticity in Mouse S1.
    Gainey MA; Aman JW; Feldman DE
    J Neurosci; 2018 May; 38(20):4749-4761. PubMed ID: 29678876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6/2 mouse model of Huntington's disease.
    Estrada-Sánchez AM; Castro D; Portillo-Ortiz K; Jang K; Nedjat-Haiem M; Levine MS; Cepeda C
    CNS Neurosci Ther; 2019 Apr; 25(4):509-518. PubMed ID: 30311425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical correlates of synapse density in a Huntington's disease mouse model.
    Zarate N; Gundry K; Yu D; Casby J; Eberly LE; Öz G; Gomez-Pastor R
    J Neurochem; 2023 Jan; 164(2):226-241. PubMed ID: 36272099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
    Heikkinen T; Lehtimäki K; Vartiainen N; Puoliväli J; Hendricks SJ; Glaser JR; Bradaia A; Wadel K; Touller C; Kontkanen O; Yrjänheikki JM; Buisson B; Howland D; Beaumont V; Munoz-Sanjuan I; Park LC
    PLoS One; 2012; 7(12):e50717. PubMed ID: 23284644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor NeuroD2 coordinates synaptic innervation and cell intrinsic properties to control excitability of cortical pyramidal neurons.
    Chen F; Moran JT; Zhang Y; Ates KM; Yu D; Schrader LA; Das PM; Jones FE; Hall BJ
    J Physiol; 2016 Jul; 594(13):3729-44. PubMed ID: 27146976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-Reaching Platform for Longitudinal Assessment of Cortical Activity and Fine Motor Coordination Defects in a Huntington Disease Mouse Model.
    Wang Y; Sepers MD; Xiao D; Raymond LA; Murphy TH
    eNeuro; 2023 Jan; 10(1):. PubMed ID: 36596592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington disease.
    Kolodziejczyk K; Parsons MP; Southwell AL; Hayden MR; Raymond LA
    PLoS One; 2014; 9(4):e94562. PubMed ID: 24728353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connectomic imaging reveals Huntington-related pathological and pharmaceutical effects in a mouse model.
    Chang WT; Puspitasari F; Garcia-Miralles M; Yeow LY; Tay HC; Koh KB; Tan LJ; Pouladi MA; Chuang KH
    NMR Biomed; 2018 Dec; 31(12):e4007. PubMed ID: 30260561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.
    Peng Q; Wu B; Jiang M; Jin J; Hou Z; Zheng J; Zhang J; Duan W
    PLoS One; 2016; 11(2):e0148839. PubMed ID: 26859386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.